Search Results
12 results found-
Midt-Norsk Prinsesse Kristinas 32 000,00 kr 32 000,00 kr Gastroenterologisk Forening TRONDHEIM Norway gate 3 63 750,00 kr 63 750,00 kr Norsk Cardiologisk Selskap Dilling Norway Balkeveien 44 c/o Den Norske Norsk gastroenterologisk Legeforening, 45 700,00 kr 45 700,00 kr forening Oslo Norway Akesgata 2 Norsk nyremedisinsk 35 000,00 kr 35 000,00 kr forening Oslo Norway Kirkegata 25 Norsk sykepleierforbund Oslo Norway Tollbugata 22 12 000,00 kr 12 000,00 kr 15 000,00 kr 15 000,00 kr Norwegian IBD Study Group Oslo Norway Lovisenberggata 17 22 500,00 kr 22 500,00 kr NSF - faggruppe for kardiologi Oslo Norway Tollbugata 22 NSFs Faggruppe for 8 000,00 kr 10 700,00 kr 18 700,00 kr Nyresykepleiere Oslo Norway Tollbugata 22 Klaus Hanssens 12 000,00 kr 12 000,00 kr Vestlandske Gastroforum Bergen/Voss Norway Vei 36 ANNET, IKKE INKLUDERT OVER - hvis informasjon ikke kan offentliggjøres individuelt av juridiske hensyn Samlet beløp som kan tilskrives verdioverføringer til slike mottagere - Art.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/norway-efpia_no_26june2024_final.pdf -
CSL is among the winners of this year’s prizes for pharmaceutical products that improve the human condition. The Prix Galien Awards “represent the very best in modern scientific discovery and innovation” and are selected by a committee of research leaders, including three Nobel laureates.
https://www.csl.com/we-are-csl/vita-original-stories/2023/what-are-the-prix-galien-usa -
Abedini MD, PhD Halfdan Wilhelmsens - - 38000 38000 (org.nr 983939821) TØNSBERG Norway alle 17, 3103-TØN St Olavs Hospital Olav Kyrres gate 17, 11 500,00 kr 11 500,00 kr Trondheim TRONDHEIM Norway 7030-TRO OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons Aggregate amount attributable to transfers of value to such Recipients - Art.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/tov-report-2022_no.pdf -
Revisione del periodo di riferimento dal 2018 al 2019 Revisione della sezione 5 "Gestione del Consenso" a causa delle circostanze eccezionali le- 04 08.05.2020 gate al COVID-19 Inserimento del nuovo sito web per la pubblicazione dei dati
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-vifor_2023-italy.pdf -
Research found slightly more than half of HAE patients who had COVID-19 experienced a swelling attack while infected.
https://www.csl.com/we-are-csl/vita-original-stories/2022/new-study-on-hae-and-covid-19 -
Revisione del periodo di riferimento dal 2018 al 2019 Revisione della sezione 5 "Gestione del Consenso" a causa delle circostanze eccezionali le- 04 08.05.2020 gate al COVID-19 Inserimento del nuovo sito web per la pubblicazione dei dati
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-italia-2022.pdf -
spesifisering er tilgjengelig bare på forespørsel fra den enkelte mottager eller vedkommende offentlige myndigheter) Norsk Diabetikersenter For Behandling Og Oslo Norge Sponhoggveien 19 16'000.00 16'000.00 Opplæring Norsk gastroenterologisk forening Oslo Norge Akersgata 2 12'000.00 12'000.00 NSFs -Landsgruppe av kardiologiske Kristiansand Norge Møllevannsveien 77C 8'000.00 8'000.00 sykepleiere Sadollah Abedini enkeltmannsforetak Tønsberg Norge Hyttebakken 5 27'295.64 27'295.64 Thomas von Lueder Cardioconsult Oslo Norge Arbins Gate 9A 10'000.00 10'000.00 Vestnorsk cardiologisk forening Bergen Norge Jonas Lies vei 65 c/o Haukeland 12'000.00 12'000.00 ANNET, IKKE INKLUDERT OVER -hvis informasjon ikke kan offentliggjøres individuelt av juridiske hensyn Helseorganisasjoner Samlet beløp som kan tilskrives verdioverføringer til slike mottagere - Art.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/disclosure-reports/disclosure-report-norway-2020.pdf -
Here’s why thousands of biotech leaders flock to the global meetup
https://www.csl.com/we-are-csl/vita-original-stories/2019/2019-bio-international-convention-philadelphia -
Chair of the Corporations Committee company-making activities, and in 2014 Co-Head of Unlisted Infrastructure Takeda, Dr Yamada was President of the of the Business Law Section of the Law served on the panel of the Australian Investments at Colonial First State Global Bill & Melinda Gates Foundation Global Mr Hussain is a member of the Innovation and Development Committee, the Human Council of Australia from 2012 to 2013, Government's Financial System Inquiry.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
He has also held the role Dr Tadataka Yamada of President on the Bill & Melinda Gates Foundation Global Health Program has been a Director and prior to that was Chairman of Research and Development at of CSL Limited since GlaxoSmithKline.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf